Literature DB >> 15287023

Different mechanisms of chromosome 16 loss of heterozygosity in well- versus poorly differentiated ductal breast cancer.

Anne-Marie Cleton-Jansen1, Horst Buerger, Natalja ter Haar, Katja Philippo, Marc J van de Vijver, Werner Boecker, Vincent T H B M Smit, Cees J Cornelisse.   

Abstract

Loss of heterozygosity (LOH) at the long arm of chromosome 16 is a frequent genetic alteration in breast cancer. It can occur by physical loss of part of or the entire chromosomal arm, resulting in a decrease in copy number or loss followed by mitotic recombination. Comparative genomic hybridization (CGH) demonstrated that well-differentiated breast tumors showed significantly more physical loss of 16q than did poorly differentiated ones and that this difference was already discernable in the preinvasive stage. However, polymorphic markers detected no difference in the frequency of 16q LOH between invasive tumors of different histological grade. Here, by combining data on LOH (n=52), fluorescence in situ hybridization (n=18) with chromosome 16-specific probes, and CGH (n=34), we show a preference in well-differentiated grade I tumors for physical loss of chromosome arm 16q, whereas in poorly differentiated grade III tumors LOH is accompanied by mitotic recombination. This clarifies the discrepancies observed between CGH and LOH for 16q in breast cancer. These different somatic genetic mechanisms may reflect the presence of multiple tumor suppressor genes that are the target of LOH at chromosome arm 16q. Copyright 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15287023     DOI: 10.1002/gcc.20070

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  17 in total

1.  High-resolution DNA analysis of human embryonic stem cell lines reveals culture-induced copy number changes and loss of heterozygosity.

Authors:  Elisa Närvä; Reija Autio; Nelly Rahkonen; Lingjia Kong; Neil Harrison; Danny Kitsberg; Lodovica Borghese; Joseph Itskovitz-Eldor; Omid Rasool; Petr Dvorak; Outi Hovatta; Timo Otonkoski; Timo Tuuri; Wei Cui; Oliver Brüstle; Duncan Baker; Edna Maltby; Harry D Moore; Nissim Benvenisty; Peter W Andrews; Olli Yli-Harja; Riitta Lahesmaa
Journal:  Nat Biotechnol       Date:  2010-03-28       Impact factor: 54.908

Review 2.  Gene therapy for carcinoma of the breast.

Authors:  M A Stoff-Khalili; P Dall; D T Curiel
Journal:  Cancer Gene Ther       Date:  2006-01-06       Impact factor: 5.987

3.  A comprehensive study of chromosome 16q in invasive ductal and lobular breast carcinoma using array CGH.

Authors:  R Roylance; P Gorman; T Papior; Y-L Wan; M Ives; J E Watson; C Collins; N Wortham; C Langford; H Fiegler; N Carter; C Gillett; P Sasieni; S Pinder; A Hanby; I Tomlinson
Journal:  Oncogene       Date:  2006-05-15       Impact factor: 9.867

4.  Genomic heterogeneity of breast tumor pathogenesis.

Authors:  Rachel E Ellsworth; Jeffrey A Hooke; Craig D Shriver; Darrell L Ellsworth
Journal:  Clin Med Oncol       Date:  2009-07-29

5.  Comparison of genetic variation of breast cancer susceptibility genes in Chinese and German populations.

Authors:  David Barzan; Marlon R Veldwijk; Carsten Herskind; Yang Li; Bo Zhang; Elena Sperk; Wei-Dong Du; Xue-Jun Zhang; Frederik Wenz
Journal:  Eur J Hum Genet       Date:  2013-03-13       Impact factor: 4.246

6.  Large-scale evaluation of candidate genes identifies associations between DNA repair and genomic maintenance and development of benzene hematotoxicity.

Authors:  Qing Lan; Luoping Zhang; Min Shen; William J Jo; Roel Vermeulen; Guilan Li; Christopher Vulpe; Sophia Lim; Xuefeng Ren; Stephen M Rappaport; Sonja I Berndt; Meredith Yeager; Jeff Yuenger; Richard B Hayes; Martha Linet; Songnian Yin; Stephen Chanock; Martyn T Smith; Nathaniel Rothman
Journal:  Carcinogenesis       Date:  2008-10-31       Impact factor: 4.944

7.  Molecular changes in primary breast tumors and the Nottingham Histologic Score.

Authors:  Rachel E Ellsworth; Jeffrey A Hooke; Brad Love; Darrell L Ellsworth; Craig D Shriver
Journal:  Pathol Oncol Res       Date:  2009-02-05       Impact factor: 3.201

Review 8.  Non-operative breast pathology: lobular neoplasia.

Authors:  Jorge S Reis-Filho; Sarah E Pinder
Journal:  J Clin Pathol       Date:  2006-12-20       Impact factor: 3.411

9.  Expression analysis of candidate breast tumour suppressor genes on chromosome 16q.

Authors:  Tom van Wezel; Marcel Lombaerts; Eddy H van Roon; Katja Philippo; Hans J Baelde; Karoly Szuhai; Cees J Cornelisse; Anne-Marie Cleton-Jansen
Journal:  Breast Cancer Res       Date:  2005-10-18       Impact factor: 6.466

10.  Association between polymorphisms in RMI1, TOP3A, and BLM and risk of cancer, a case-control study.

Authors:  Karin Broberg; Elizabeth Huynh; Karin Schläwicke Engström; Jonas Björk; Maria Albin; Christian Ingvar; Håkan Olsson; Mattias Höglund
Journal:  BMC Cancer       Date:  2009-05-11       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.